Browse > Article
http://dx.doi.org/10.4062/biomolther.2015.054

Diphlorethohydroxycarmalol Suppresses Ultraviolet B-Induced Matrix Metalloproteinases via Inhibition of JNK and ERK Signaling in Human Keratinocytes  

Piao, Mei Jing (School of Medicine, College of Natural Sciences, Jeju National University)
Kumara, Madduma Hewage Susara Ruwan (School of Medicine, College of Natural Sciences, Jeju National University)
Kim, Ki Cheon (School of Medicine, College of Natural Sciences, Jeju National University)
Kang, Kyoung Ah (School of Medicine, College of Natural Sciences, Jeju National University)
Kang, Hee Kyoung (School of Medicine, College of Natural Sciences, Jeju National University)
Lee, Nam Ho (Department of Chemistry, College of Natural Sciences, Jeju National University)
Hyun, Jin Won (School of Medicine, College of Natural Sciences, Jeju National University)
Publication Information
Biomolecules & Therapeutics / v.23, no.6, 2015 , pp. 557-563 More about this Journal
Abstract
Skin aging is the most readily observable process involved in human aging. Ultraviolet B (UVB) radiation causes photo-oxidation via generation of reactive oxygen species (ROS), thereby damaging the nucleus and cytoplasm of skin cells and ultimately leading to cell death. Recent studies have shown that high levels of solar UVB irradiation induce the synthesis of matrix metalloproteinases (MMPs) in skin fibroblasts, causing photo-aging and tumor progression. The MMP family is involved in the breakdown of extracellular matrix in normal physiological processes such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes such as arthritis and metastasis. We investigated the effect of diphlorethohydroxycarmalol (DPHC) against damage induced by UVB radiation in human skin keratinocytes. In UVB-irradiated cells, DPHC significantly reduced expression of MMP mRNA and protein, as well as activation of MMPs. Furthermore, DPHC reduced phosphorylation of ERK and JNK, which act upstream of c-Fos and c-Jun, respectively; consequently, DPHC inhibited the expression of c-Fos and c-Jun, which are key components of activator protein-1 (AP-1, up-regulator of MMPs). Additionally, DPHC abolished the DNA-binding activity of AP-1, and thereby prevented AP-1-mediated transcriptional activation. These data demonstrate that by inactivating ERK and JNK, DPHC inhibits induction of MMPs triggered by UVB radiation.
Keywords
Diphlorethohydroxycarmalol; Human skin keratinocytes; Matrix metalloproteinases; Photo-aging; Ultraviolet B;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Brenneisen, P., Briviba, K., Wlaschek, M., Wenk, J. and Scharffetter-Kochanek, K. (1997) Hydrogen peroxide ($H_2O_2$) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. Free Radic. Biol. Med. 22, 515-524.   DOI
2 Brenneisen, P., Sies, H. and Scharffetter-Kochanek, K. (2002) Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events. Ann. N. Y. Acad. Sci. 973, 31-43.   DOI
3 Brinckerhoff, C. E. and Matrisian, L. M. (2002) Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 3, 207-214.   DOI
4 Cano, E., Hazzalin, C. A. and Mahadevan, L. C. (1994) Anisomycinactivated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and-2 are implicated in the induction of cfos and c-jun. Mol. Cell Biol. 14, 7352-7362.   DOI
5 Chen, K., Chen, J., Li, D., Zhang, X. and Mehta, J. L. (2004) Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension 44, 655-661.   DOI
6 Crawford, H. C. and Matrisian, L. M. (1996) Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49, 20-37.   DOI
7 Dasgupta, J., Kar, S., Liu, R., Joseph, J., Kalyanaraman, B., Remington, S. J., Chen, C. and Melendez, J. A. (2010) Reactive oxygen species control senescence-associated matrix metalloproteinase-1 through c-Jun-N-terminal kinase. J. Cell Physiol. 225, 52-62.   DOI
8 Davidson, B., Givant-Horwitz, V., Lazarovici, P., Risberg, B., Nesland, J., Trope, C. G., Schaefer, E. and Reich, R. (2003) Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma. Clin. Exp. Metastasis 20, 621-631.   DOI
9 Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B.A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R. and Futreal, P. A. (2002) Mutations of the BRAF gene in human cancer. Nature 417, 949-954.   DOI
10 Eliopoulos, A. G. and Young, L. S. (1998) Activation of the cJun Nterminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 16, 1731-1742.   DOI
11 Fagot, D., Asselineau, D. and Bernerd, F. (2002) Direct role of human dermal fibroblasts and indirect participation of epidermal keratinocytes in MMP-1 production after UV-B irradiation. Arch. Dermatol. Res. 293, 576-583.   DOI
12 Farrell, P. J, Rowe, D. T, Rooney, C. M. and Kouzarides, T. (1989) Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J. 8, 127-132.
13 Glover, J. N. and Harrison, S. C. (1995) Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 373, 257-261.   DOI
14 Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. L., Scherle, P. A. and Trzaskos, J. M. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632.   DOI
15 Fisher, G. J., Kang, S., Varani, J., Bata-Csorgo, Z., Wan, Y., Datta, S. and Voorhees, J. J. (2002) Mechanisms of photoaging and chronological skin aging. Arch. Dermatol. 138, 1462-1470.
16 Frost, J. A, Geppert, T. D, Cobb, M. H. and Feramisco, J. R. (1994) A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc. Natl. Acad. Sci. U.S.A. 91, 3844-3848.   DOI
17 Goffin, L., Seguin-Estevez, Q., Alvarez, M., Reith, W. and Chizzolini, C. (2010) Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts. Arthritis Res. Ther. 12, R73.   DOI
18 Heo, S. J. and Jeon, Y. J. (2009) Evaluation of diphlorethohydroxycarmalol isolated from Ishige okamurae for radical scavenging activity and its protective effect against $H_2O_2$-induced cell damage. Process Biochem. 44, 412-418.   DOI
19 Heo, S. J., Hwang, J. Y., Choi, J. I., Han, J. S., Kim, H. J. and Jeon, Y. J. (2009) Diphlorethohydroxycarmalol isolated from Ishige okamurae, a brown algae, a potent [alpha]-glucosidase and [alpha]-amylase inhibitor, alleviates postprandial hyperglycemia in diabetic mice. Eur. J. Pharmacol. 615, 252-256.   DOI
20 Heo, S. J., Ko, S. C., Kang, S. M., Cha, S. H., Lee, S. H., Kang, D. H., Jung, W. K., Affan, A., Oh, C. and Jeon, Y. J. (2010) Inhibitory effect of diphlorethohydroxycarmalol on melanogenesis and its protective effect against UV-B radiation-induced cell damage. Food Chem. Toxicol. 48, 1355-1361.   DOI
21 Jacob, M. P. (2003) Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed. Pharmacother. 57, 195-202.   DOI
22 Jo, W. S., Yang, K. M., Park, H. S., Kim, G. Y., Nam, B. H., Jeong, M. H. and Choi, Y. J. (2012) Effect of microalgal extracts of tetraselmis suecica against UVB-induced photoaging in human skin fibroblasts. Toxicol. Res. 28, 241-248.   DOI
23 Kahari, V. M. and Saarialho-Kere, U. (1997) Matrix metalloproteinases in skin. Exp. Dermatol. 6, 199-213.   DOI
24 Kang, K. A., Zhang, R., Piao, M. J., Ko, D. O., Wang, Z. H., Kim, B. J., Park, J. W., Kim, H. S., Kim, D. H. and Hyun, J. W. (2008a) Protective effect of irisolidone, a metabolite of kakkalide, against hydrogen peroxide induced cell damage via antioxidant effect. Bioorg. Med. Chem. 16, 1133-1141.   DOI
25 Kang, K. A., Zhang, R., Piao, M. J., Ko, D. O., Wang, Z. H., Lee, K., Kim, B. J., Shin, T., Park, J. W., Lee, N. H., Yoo, B. S. and Hyun, J. W. (2008b) Inhibitory effects of triphlorethol-A on MMP-1 induced by oxidative stress in human keratinocytes via ERK and AP-1 inhibition. J. Toxicol. Environ. Health A. 71, 992-999.   DOI
26 Kieser, A., Kilger, E., Gires, O., Ueffing, M., Kolch, W. and Hammerschmidt, W. (1997) Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J. 16, 6478-6485.   DOI
27 Mook, O. R., Frederiks, W. M. and Van Noorden, C. J. (2004). The role of gelatinases in colorectal cancer progression and metastasis. Biochim. Biophys. Acta 1705, 69-89.
28 Kim, C., Ryu, H. C. and Kim, J. H. (2010) Low-dose UVB irradiation stimulates matrix metalloproteinase-1 expression via a BLT2-linked pathway in HaCaT cells. Exp. Mol. Med. 42, 833-841.   DOI
29 Kim, H. H., Shin, C. M., Park, C. H., Kim, K. H., Cho, K. H., Eun, H. C. and Chung, J. H. (2005) Eicosapentaenoic acid inhibits UVinduced MMP-1 expression in human dermal fibroblasts. J. Lipid Res. 46, 1712-1720.   DOI
30 Lin, C. W., Georgescu, H. I. and Evans, C. H. (1993) The role of AP-1 in matrix metalloproteinase gene expression. Agents Actions 39, 215-218.   DOI
31 Murphy, L. O, Smith, S., Chen, R. H, Fingar, D. C. and Blenis, J. (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4, 556-564.   DOI
32 Purcell, W. T., Rudek, M. A. and Hidalgo, M. (2002) Development of matrix metalloproteinase inhibitors in cancer therapy. Hematol. Oncol. Clin. North Am. 16, 1189-1227.   DOI
33 Reel, B., Oktay, G., Ozkal, S., Islekel, H., Ozer, E., Ozsarlak-Sozer, G., Cavdar, Z., Akhisaroglu, S. T. and Kerry Z. (2009) MMP-2 and MMP-9 alteration in response to collaring in rabbits: the effects of endothelin receptor antagonism J. Cardiovasc. Pharmacol. Ther. 14, 292-301.   DOI
34 Ren, S. W., Li, J., Wang, W. and Guan, H. S. (2010) Protective effects of kappa-ca3000+CP against ultraviolet-induced damage in HaCaT and MEF cells. J. Photochem. Photobiol. B. 101, 22-30.   DOI
35 Wenk, J., Brenneisen, P., Wlaschek, M., Poswig, A., Briviba, K., Oberley, T. D. and Scharffetter-Kochanek, K. (1999) Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J. Biol. Chem. 274, 25869-25876.   DOI
36 Sunami, E., Tsuno, N., Osada, T., Saito, S., Kitayama, J., Tomozawa, S., Tsuruo, T., Shibata, Y., Muto, T. and Nagawa, H. (2000) MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist 5, 108-114.   DOI
37 Tsareva, S. A., Moriggl, R., Corvinus, F. M., Wiederanders, B., Schutz, A., Kovacic, B. and Friedrich, K. (2007) Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 9, 279-291.   DOI
38 Wenham, R., Calingaert, B., Ali, S., McClean, K., Whitaker, R., Bentley, R., Lancaster, J., Schildkraut, J., Marks, J. and Berchuck, A. (2003) Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer. J. Soc. Gynecol. Investig. 10, 381-387.   DOI
39 Westermarck, J. and Kahari, V. M. (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13, 781-792.   DOI
40 Wu, H. M., Wen, H. C. and Lin, W. W. (2002) Proteasome inhibitors stimulate interleukin-8 expression via Ras and apoptosis signalregulating kinase-dependent extracellular signal-related kinase and c-Jun N-terminal kinase activation. Am. J. Respir. Cell Mol. Biol. 27, 234-243.   DOI
41 Yaar, M. and Gilchrest, B. A. (2007) Photoageing: mechanism, prevention and therapy. Br. J. Dermatol. 157, 874-887.   DOI
42 Bogoyevitch, M. A., Ngoei, K. R., Zhao, T. T., Yeap, Y. Y. and Ng, D. C. (2010) c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges. Biochim. Biophys. Acta 1804, 463-475.   DOI
43 Benbow, U. and Brinckerhoff, C.E. (1997) The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15, 519-526.   DOI
44 Berne, B., Vahlquist, A., Fischer, T., Danielson, B. G. and Berne, C. (1984) UV treatment of uraemic pruritus reduces the vitamin A content of the skin. Eur. J. Clin. Invest. 14, 203-206.   DOI